Department of Medicine (Neurology), University of Alberta, Edmonton, Alberta, Canada.
Mov Disord. 2011 Jul;26(8):1443-50. doi: 10.1002/mds.23700. Epub 2011 Mar 25.
Age-related ventricular enlargement is accelerated in Alzheimer's disease, but its relationship to cognitive decline in Parkinson's disease is less clear, even though dementia is common in Parkinson's disease. Our goals were to determine if greater enlargement of the ventricles and gray or white matter atrophy occurred in Parkinson's disease patients developing cognitive decline. Older nondemented patients with Parkinson's disease (33) and age- and sex-matched controls (39) were recruited and prospectively assessed for the development of significant cognitive decline over 36 months. Magnetic resonance imaging was obtained every 18 months, and ventricular volume and total brain gray and white matter volumes were measured using reliable segmentation of T1-weighted volumetric scans. Subjects with incidental intracranial abnormalities, an atypical course, and stroke as well as dropouts were excluded from a cohort of 52 patients and 50 controls. Among 33 patients and 39 controls, 10 patients and 3 controls developed significant cognitive impairment or dementia. Ventricular change and Parkinson's disease status were significantly associated with dementia. Ventricular change was significantly correlated with change in Mini-Mental Status Examination in the Parkinson's disease with dementia group (r = 0.87, P = .001). Gray matter atrophy was greater in Parkinson's disease with dementia, with similar change over time in both Parkinson's disease and Parkinson's disease with dementia. White matter volumes were not significantly different between Parkinson's disease and Parkinson's disease with dementia; however, the decrease over time might be greater in Parkinson's disease with dementia. Ventricular dilatation occurs early in the course of significant cognitive decline in patients with Parkinson's disease, possibly reflecting both cortical gray and white matter loss.
年龄相关性脑室扩大在阿尔茨海默病中加速,但在帕金森病中与认知能力下降的关系尚不清楚,尽管痴呆症在帕金森病中很常见。我们的目标是确定在认知能力下降的帕金森病患者中是否存在脑室扩大和灰质或白质萎缩。招募了年龄较大、无痴呆的帕金森病患者(33 名)和年龄、性别匹配的对照组(39 名),并前瞻性评估了他们在 36 个月内出现显著认知能力下降的情况。每 18 个月进行一次磁共振成像检查,使用 T1 加权容积扫描的可靠分割方法测量脑室容积和总脑灰质和白质体积。从 52 名患者和 50 名对照组中排除了存在偶然颅内异常、非典型病程和中风以及失访的患者。在 33 名患者和 39 名对照组中,有 10 名患者和 3 名对照组出现了显著的认知障碍或痴呆。脑室变化和帕金森病状况与痴呆显著相关。在痴呆的帕金森病患者中,脑室变化与简易精神状态检查的变化显著相关(r = 0.87,P =.001)。痴呆的帕金森病患者灰质萎缩更为明显,帕金森病和痴呆的帕金森病患者的灰质变化时间相似。帕金森病和痴呆的帕金森病患者的白质体积无显著差异;然而,痴呆的帕金森病患者的白质体积随时间的减少可能更大。在帕金森病患者出现显著认知能力下降的早期,脑室就开始扩张,这可能反映了皮质灰质和白质的丧失。